Our Members
As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
PRI Members represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
Neobe Therapeutics
Pedro Correa de Sampaio
CEO
Neobe is building a platform for the engineering of live biotherapeutics aimed at removing stromal barriers to immune infiltration in solid tumours, in order to enable existing immunotherapies in current non responding cancer patients.
Nestlé Health Science
Laurent Ameye
Global Regulatory Compliance Manager
Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care.
Nexbiome Therapeutics
Stanislas Desjonquères
CEO
We transform academic therapeutic and microbiome-based projects into products for Humans. Our value is to source, fund and operate these projects.
Orion Corporation Orion Pharma R&D
Mirja Huhtinen
Director, Animal Health R&D
Orion Pharma Animal Health R&D develops innovative medicinal, ProHealth and microbiome products to global markets. Our flagship microbiome product is Broilact.
PharmaBiome AG
Tomas de Wouters
Co-Founder & CEO
Pioneering the development of microbiome-based therapies using proprietary tools for their design and production.
Phycell (INSERM U1003) – University of Lille
Mathias Chamalliard
Research Director at INSERM - Deputy Director of the Laboratory of Cell Physiology
The Chamaillard laboratory is interested in defining how mucosal immune response to the microbiota contribute to microbial tolerance, host defense and antitumoral immunity, and how deregulation of these processes break down in Crohn's disease and colitis-associated colorectal cancer. Crohn's disease affects millions of individuals worldwide through the influence of several genetic and environmental factors.
POSTECH
Sin-hyeog Im
Professor
Pohang University of Science and Technology is devoted to nurturing the leaders who make a difference globally, conducting cutting-edge research with outcomes that transform our daily lives, and directly contributing to the betterment of society through science and technology.
Probiotical Research
Marco Pane
CSO
Probiotical is an Italian family-owned company specialized since 1985 in probiotics manufacture, from the raw material to the finished products, with very high quality, guaranteed stability and scientifically backed strains. We are driving innovation in a variety of functionalities and technologies.
